Stock Analysis
Euronext Paris Growth Leaders With Insider Holdings Above 10%
Reviewed by Simply Wall St
Amidst a backdrop of heightened trade tensions and fluctuating market dynamics across Europe, with France's CAC 40 Index experiencing a notable decline, investors are increasingly attentive to the stability and potential growth opportunities within the Euronext Paris. In this context, companies with substantial insider ownership often signal strong confidence in the firm’s prospects from those who know it best—its leaders and founders. This article explores three such growth-oriented companies on the Euronext Paris where insider stakes exceed 10%, potentially offering a beacon of resilience and long-term commitment in uncertain times.
Top 10 Growth Companies With High Insider Ownership In France
Name | Insider Ownership | Earnings Growth |
VusionGroup (ENXTPA:VU) | 13.5% | 24.3% |
Groupe OKwind Société anonyme (ENXTPA:ALOKW) | 24.8% | 39.4% |
Adocia (ENXTPA:ADOC) | 11.9% | 63% |
La Française de l'Energie (ENXTPA:FDE) | 20.1% | 31.8% |
STIF Société anonyme (ENXTPA:ALSTI) | 10.7% | 28.5% |
Arcure (ENXTPA:ALCUR) | 21.4% | 27.5% |
S.M.A.I.O (ENXTPA:ALSMA) | 17.3% | 35.2% |
Munic (ENXTPA:ALMUN) | 29.4% | 149.2% |
OSE Immunotherapeutics (ENXTPA:OSE) | 25.6% | 5.9% |
MedinCell (ENXTPA:MEDCL) | 16.4% | 69.6% |
Here's a peek at a few of the choices from the screener.
Lectra (ENXTPA:LSS)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Lectra SA offers industrial intelligence solutions across the fashion, automotive, and furniture sectors in various global regions including Northern Europe, Southern Europe, the Americas, and Asia Pacific, with a market capitalization of approximately €1.07 billion.
Operations: The company generates revenue from its operations in the Americas and Asia Pacific, with contributions of €170.33 million and €110.28 million respectively.
Insider Ownership: 19.6%
Lectra, a French growth company with high insider ownership, shows promising financial trends despite some challenges. Its revenue is expected to grow at 10.8% annually, outpacing the national market's 5.7%. Earnings are projected to increase significantly by 28.6% per year. However, its Return on Equity might remain modest at 13.4% in three years. Recently, Lectra reported a slight dip in net income for the first half of 2024 but remains undervalued by analysts' standards, trading at 36.8% below estimated fair value.
- Get an in-depth perspective on Lectra's performance by reading our analyst estimates report here.
- Insights from our recent valuation report point to the potential undervaluation of Lectra shares in the market.
MedinCell (ENXTPA:MEDCL)
Simply Wall St Growth Rating: ★★★★★☆
Overview: MedinCell S.A. is a French pharmaceutical company specializing in the development of long-acting injectable medications across multiple therapeutic areas, with a market capitalization of approximately €463.23 million.
Operations: The company generates its revenue primarily from the pharmaceuticals segment, amounting to €11.95 million.
Insider Ownership: 16.4%
MedinCell, a French growth company with substantial insider ownership, reported a decrease in annual revenue and net loss for the year ending March 2024. Despite setbacks in its Phase 3 trial for F14, significant improvements were noted in secondary endpoints and safety profiles. The company is expected to grow revenues at 43.8% annually, outstripping the French market's 5.7%. MedinCell remains unprofitable but is forecasted to achieve profitability within three years, reflecting robust future growth prospects.
- Dive into the specifics of MedinCell here with our thorough growth forecast report.
- Our comprehensive valuation report raises the possibility that MedinCell is priced higher than what may be justified by its financials.
OVH Groupe (ENXTPA:OVH)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: OVH Groupe S.A. is a global provider of public and private cloud services, shared hosting, and dedicated server solutions, with a market capitalization of approximately €1.05 billion.
Operations: The company generates revenue through three main segments: Public Cloud (€169.01 million), Private Cloud (€589.61 million), and Web cloud (€185.43 million).
Insider Ownership: 10.5%
OVH Groupe, a French growth company with substantial insider ownership, is set to innovate with its new ADV-Gen3 Bare Metal servers. These servers showcase significant advancements in CPU and network capabilities, promising enhanced performance at competitive prices. Despite a highly volatile share price recently, OVH's revenue is expected to grow by 10% annually, outpacing the French market average of 5.7%. The company is forecasted to become profitable within the next three years, indicating potential for robust growth ahead.
- Click here and access our complete growth analysis report to understand the dynamics of OVH Groupe.
- In light of our recent valuation report, it seems possible that OVH Groupe is trading behind its estimated value.
Seize The Opportunity
- Reveal the 21 hidden gems among our Fast Growing Euronext Paris Companies With High Insider Ownership screener with a single click here.
- Have you diversified into these companies? Leverage the power of Simply Wall St's portfolio to keep a close eye on market movements affecting your investments.
- Enhance your investing ability with the Simply Wall St app and enjoy free access to essential market intelligence spanning every continent.
Ready To Venture Into Other Investment Styles?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About ENXTPA:MEDCL
MedinCell
A pharmaceutical company, develops long acting injectables in various therapeutic areas in France.
High growth potential with worrying balance sheet.